- Home
- DSGN vs DDD Comparison
DSGN vs DDD Comparison
Compare DSGN & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- DDD
- Stock Information
- Founded
- DSGN 2017
- DDD 1986
- Country
- DSGN United States
- DDD United States
- Employees
- DSGN N/A
- DDD N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- DDD Computer peripheral equipment
- Sector
- DSGN Health Care
- DDD Technology
- Exchange
- DSGN Nasdaq
- DDD Nasdaq
- Market Cap
- DSGN 224.8M
- DDD 268.5M
- IPO Year
- DSGN 2021
- DDD N/A
- Fundamental
- Price
- DSGN $3.50
- DDD $2.37
- Analyst Decision
- DSGN Hold
- DDD Hold
- Analyst Count
- DSGN 1
- DDD 3
- Target Price
- DSGN $4.00
- DDD $3.50
- AVG Volume (30 Days)
- DSGN 140.5K
- DDD 2.3M
- Earning Date
- DSGN 05-07-2025
- DDD 05-12-2025
- Dividend Yield
- DSGN N/A
- DDD N/A
- EPS Growth
- DSGN N/A
- DDD N/A
- EPS
- DSGN N/A
- DDD N/A
- Revenue
- DSGN N/A
- DDD $440,121,000.00
- Revenue This Year
- DSGN N/A
- DDD N/A
- Revenue Next Year
- DSGN N/A
- DDD $5.15
- P/E Ratio
- DSGN N/A
- DDD N/A
- Revenue Growth
- DSGN N/A
- DDD N/A
- 52 Week Low
- DSGN $2.60
- DDD $1.71
- 52 Week High
- DSGN $7.77
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- DSGN 42.85
- DDD 62.44
- Support Level
- DSGN $3.23
- DDD $1.92
- Resistance Level
- DSGN $5.04
- DDD $2.06
- Average True Range (ATR)
- DSGN 0.48
- DDD 0.12
- MACD
- DSGN -0.05
- DDD 0.08
- Stochastic Oscillator
- DSGN 15.06
- DDD 91.54
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.